These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24457553)

  • 21. Implication of the 5-HT2A and 5-HT2C (but not 5HT1A) receptors located within the periaqueductal gray in the elevated plus-maze test-retest paradigm in mice.
    Gomes KS; Nunes-De-Souza RL
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1261-9. PubMed ID: 19625008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression.
    Wesołowska A; Nikiforuk A
    Neuropharmacology; 2007 Apr; 52(5):1274-83. PubMed ID: 17320917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepam.
    Moser PC; Tricklebank MD; Middlemiss DN; Mir AK; Hibert MF; Fozard JR
    Br J Pharmacol; 1990 Feb; 99(2):343-9. PubMed ID: 1970269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of 5-HT2 and 5-HT4 receptor antagonists to modify drug induced disinhibitory effects in the mouse light/dark test.
    Costall B; Naylor RJ
    Br J Pharmacol; 1997 Nov; 122(6):1105-18. PubMed ID: 9401775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-HT4 receptor-mediated modulation of 5-HT release in the rat hippocampus in vivo.
    Ge J; Barnes NM
    Br J Pharmacol; 1996 Apr; 117(7):1475-80. PubMed ID: 8730742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Propulsion in guinea pig colon induced by 5-hydroxytryptamine (HT) via 5-HT4 and 5-HT3 receptors.
    Jin JG; Foxx-Orenstein AE; Grider JR
    J Pharmacol Exp Ther; 1999 Jan; 288(1):93-7. PubMed ID: 9862758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined blockade of 5-HT3- and 5-HT4-serotonin receptors inhibits colonic functions in conscious rats and mice.
    Nagakura Y; Kontoh A; Tokita K; Tomoi M; Shimomura K; Kadowaki M
    J Pharmacol Exp Ther; 1997 Apr; 281(1):284-90. PubMed ID: 9103508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anxiolytic-like effect of 5-HT(2) ligands and benzodiazepines co-administration: comparison of two animal models of anxiety (the four-plate test and the elevated plus maze).
    Massé F; Nic Dhonnchadha BA; Hascoët M; Bourin M
    Behav Brain Res; 2007 Feb; 177(2):214-26. PubMed ID: 17175036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. R-zacopride, a 5-HT3 antagonist/5-HT4 agonist, reduces sleep apneas in rats.
    Carley DW; Depoortere H; Radulovacki M
    Pharmacol Biochem Behav; 2001; 69(1-2):283-9. PubMed ID: 11420096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissociation between anxiolytic and hypomnestic effects for combined extracts of zingiber officinale and ginkgo biloba, as opposed to diazepam.
    Hasenöhrl RU; Topic B; Frisch C; Häcker R; Mattern CM; Huston JP
    Pharmacol Biochem Behav; 1998 Feb; 59(2):527-35. PubMed ID: 9477004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement of place and object recognition memory in young adult and old rats by RS 67333, a partial agonist of 5-HT4 receptors.
    Lamirault L; Simon H
    Neuropharmacology; 2001 Dec; 41(7):844-53. PubMed ID: 11684148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk assessment behaviour: evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test.
    Griebel G; Rodgers RJ; Perrault G; Sanger DJ
    Pharmacol Biochem Behav; 1997 Aug; 57(4):817-27. PubMed ID: 9259011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of GABAB receptor ligands in animal tests of depression and anxiety.
    Frankowska M; Filip M; Przegaliński E
    Pharmacol Rep; 2007; 59(6):645-55. PubMed ID: 18195453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison between Dark Agouti and Sprague-Dawley rats in their behaviour on the elevated plus-maze, open-field apparatus and activity meters, and their response to diazepam.
    Mechan AO; Moran PM; Elliott M; Young AJ; Joseph MH; Green R
    Psychopharmacology (Berl); 2002 Jan; 159(2):188-95. PubMed ID: 11862348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anxiolytic-like effect of way-100635 microinfusions into the median (but not dorsal) raphe nucleus in mice exposed to the plus-maze: influence of prior test experience.
    Canto-de-Souza A; Luiz Nunes-de-Souza R; Rodgers RJ
    Brain Res; 2002 Feb; 928(1-2):50-9. PubMed ID: 11844471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-HT receptor subtypes involved in the anxiogenic-like action and associated Fos response of acute fluoxetine treatment in rats.
    Salchner P; Singewald N
    Psychopharmacology (Berl); 2006 Apr; 185(3):282-8. PubMed ID: 16521035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RS 23597-190: a potent and selective 5-HT4 receptor antagonist.
    Eglen RM; Bley K; Bonhaus DW; Clark RD; Hegde SS; Johnson LG; Leung E; Wong EH
    Br J Pharmacol; 1993 Sep; 110(1):119-26. PubMed ID: 8220871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anxiolytic-like profiles of histamine H3 receptor agonists in animal models of anxiety: a comparative study with antidepressants and benzodiazepine anxiolytic.
    Yokoyama F; Yamauchi M; Oyama M; Okuma K; Onozawa K; Nagayama T; Shinei R; Ishikawa M; Sato Y; Kakui N
    Psychopharmacology (Berl); 2009 Aug; 205(2):177-87. PubMed ID: 19357839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of the 5-HT3 receptor antagonist, RS-42358-197, in animal models of anxiety.
    Costall B; Domeney AM; Kelly ME; Tomkins DM; Naylor RJ; Wong EH; Smith WL; Whiting RL; Eglen RM
    Eur J Pharmacol; 1993 Mar; 234(1):91-9. PubMed ID: 8097165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic EMD 68843 injections reduce anxiety in the shock-probe, but not the plus-maze test.
    Treit D; Degroot A; kashluba S; Bartoszyk GD
    Eur J Pharmacol; 2001 Mar; 414(2-3):245-8. PubMed ID: 11239925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.